Covid-19 Impact on Global Gut Microbiome Market Size, Status and Forecast 2020-2026

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Gut Microbiome Revenue
• 1.4 Covid-19 Implications on Market by Disease
  • 1.4.1 Global Gut Microbiome Market Size Growth Rate by Disease: 2020 VS 2026
  • 1.4.2 Obesity
  • 1.4.3 Inflammatory Bowel Disease (IBD)
  • 1.4.4 Diabetes
  • 1.4.5 Others
• 1.5 Market by Application
  • 1.5.1 Global Gut Microbiome Market Share by Application: 2020 VS 2026
  • 1.5.2 Human
  • 1.5.3 Animal
• 1.6 Coronavirus Disease 2019 (Covid-19): Gut Microbiome Industry Impact
  • 1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
  • 1.6.2 Covid-19 Impact: Commodity Prices Indices
  • 1.6.3 Covid-19 Impact: Global Major Government Policy
• 1.7 Study Objectives
• 1.8 Years Considered

2 Global Growth Trends

• 2.1 Covid-19 Implications on Global Gut Microbiome Market Perspective (2015-2026)
• 2.2 Covid-19 Implications on Global Gut Microbiome Growth Trends by Regions
  • 2.2.1 Gut Microbiome Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Gut Microbiome Historic Market Share by Regions (2015-2020)
  • 2.2.3 Gut Microbiome Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Gut Microbiome Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Gut Microbiome Players (Opinion Leaders)

3 Covid-19 Implications on Competition Landscape by Key Players

• 3.1 Global Top Gut Microbiome Players by Market Size
  • 3.1.1 Global Top Gut Microbiome Players by Revenue (2015-2020)
  • 3.1.2 Global Gut Microbiome Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Gut Microbiome Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Gut Microbiome Market Concentration Ratio
  • 3.2.1 Global Gut Microbiome Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Gut Microbiome Revenue in 2019
• 3.3 Gut Microbiome Key Players Head office and Area Served
• 3.4 Key Players Gut Microbiome Product Solution and Service
• 3.5 Date of Enter into Gut Microbiome Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Covid-19 Implications on Market Size by Disease (2015-2026)

• 4.1 Global Gut Microbiome Historic Market Size by Disease (2015-2020)
• 4.2 Global Gut Microbiome Forecasted Market Size by Disease (2021-2026)

5 Covid-19 Implications on Market Size by Application (2015-2026)

• 5.1 Global Gut Microbiome Market Size by Application (2015-2020)
• 5.2 Global Gut Microbiome Forecasted Market Size by Application (2021-2026)

6 North America Impact of COVID-19

• 6.1 North America Gut Microbiome Market Size (2015-2020)
• 6.2 Gut Microbiome Key Players in North America (2019-2020)
• 6.3 North America Gut Microbiome Market Size by Disease (2015-2020)
• 6.4 North America Gut Microbiome Market Size by Application (2015-2020)

7 Europe Impact of COVID-19

• 7.1 Europe Gut Microbiome Market Size (2015-2020)
• 7.2 Gut Microbiome Key Players in Europe (2019-2020)
• 7.3 Europe Gut Microbiome Market Size by Disease (2015-2020)
• 7.4 Europe Gut Microbiome Market Size by Application (2015-2020)

8 China Impact of COVID-19

• 8.1 China Gut Microbiome Market Size (2015-2020)
• 8.2 Gut Microbiome Key Players in China (2019-2020)
• 8.3 China Gut Microbiome Market Size by Disease (2015-2020)
• 8.4 China Gut Microbiome Market Size by Application (2015-2020)

9 Japan Impact of COVID-19

• 9.1 Japan Gut Microbiome Market Size (2015-2020)
• 9.2 Gut Microbiome Key Players in Japan (2019-2020)
• 9.3 Japan Gut Microbiome Market Size by Disease (2015-2020)
• 9.4 Japan Gut Microbiome Market Size by Application (2015-2020)

10 Southeast Asia Impact of COVID-19

• 10.1 Southeast Asia Gut Microbiome Market Size (2015-2020)
• 10.2 Gut Microbiome Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Gut Microbiome Market Size by Type (2015-2020)
• 10.4 Southeast Asia Gut Microbiome Market Size by Application (2015-2020)

11 India Impact of COVID-19

• 11.1 India Gut Microbiome Market Size (2015-2020)
• 11.2 Gut Microbiome Key Players in India (2019-2020)
• 11.3 India Gut Microbiome Market Size by Type (2015-2020)
• 11.4 India Gut Microbiome Market Size by Application (2015-2020)

12 Central & South America Impact of COVID-19

• 12.1 Central & South America Gut Microbiome Market Size (2015-2020)
• 12.2 Gut Microbiome Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Gut Microbiome Market Size by Type (2015-2020)
• 12.4 Central & South America Gut Microbiome Market Size by Application (2015-2020)

13Key Players Profiles

• 13.1 Viome
  • 13.1.1 Viome Company Details
  • 13.1.2 Viome Business Overview and Its Total Revenue
  • 13.1.3 Viome Gut Microbiome Introduction
  • 13.1.4 Viome Revenue in Gut Microbiome Business (2015-2020))
  • 13.1.5 Viome Recent Development and Reaction to COVID-19
• 13.2 Carbiotix
  • 13.2.1 Carbiotix Company Details
  • 13.2.2 Carbiotix Business Overview and Its Total Revenue
  • 13.2.3 Carbiotix Gut Microbiome Introduction
  • 13.2.4 Carbiotix Revenue in Gut Microbiome Business (2015-2020)
  • 13.2.5 Carbiotix Recent Development and Reaction to COVID-19
• 13.3 Ixcela, Inc
  • 13.3.1 Ixcela, Inc Company Details
  • 13.3.2 Ixcela, Inc Business Overview and Its Total Revenue
  • 13.3.3 Ixcela, Inc Gut Microbiome Introduction
  • 13.3.4 Ixcela, Inc Revenue in Gut Microbiome Business (2015-2020)
  • 13.3.5 Ixcela, Inc Recent Development and Reaction to COVID-19
• 13.4 Novome Biotechnologies
  • 13.4.1 Novome Biotechnologies Company Details
  • 13.4.2 Novome Biotechnologies Business Overview and Its Total Revenue
  • 13.4.3 Novome Biotechnologies Gut Microbiome Introduction
  • 13.4.4 Novome Biotechnologies Revenue in Gut Microbiome Business (2015-2020)
  • 13.4.5 Novome Biotechnologies Recent Development and Reaction to COVID-19
• 13.5 Kintai Therapeutics
  • 13.5.1 Kintai Therapeutics Company Details
  • 13.5.2 Kintai Therapeutics Business Overview and Its Total Revenue
  • 13.5.3 Kintai Therapeutics Gut Microbiome Introduction
  • 13.5.4 Kintai Therapeutics Revenue in Gut Microbiome Business (2015-2020)
  • 13.5.5 Kintai Therapeutics Recent Development and Reaction to COVID-19
• 13.6 ProDigest
  • 13.6.1 ProDigest Company Details
  • 13.6.2 ProDigest Business Overview and Its Total Revenue
  • 13.6.3 ProDigest Gut Microbiome Introduction
  • 13.6.4 ProDigest Revenue in Gut Microbiome Business (2015-2020)
  • 13.6.5 ProDigest Recent Development and Reaction to COVID-19
• 13.7 Caelus Health
  • 13.7.1 Caelus Health Company Details
  • 13.7.2 Caelus Health Business Overview and Its Total Revenue
  • 13.7.3 Caelus Health Gut Microbiome Introduction
  • 13.7.4 Caelus Health Revenue in Gut Microbiome Business (2015-2020)
  • 13.7.5 Caelus Health Recent Development and Reaction to COVID-19
• 13.8 LNC Therapeutics
  • 13.8.1 LNC Therapeutics Company Details
  • 13.8.2 LNC Therapeutics Business Overview and Its Total Revenue
  • 13.8.3 LNC Therapeutics Gut Microbiome Introduction
  • 13.8.4 LNC Therapeutics Revenue in Gut Microbiome Business (2015-2020)
  • 13.8.5 LNC Therapeutics Recent Development and Reaction to COVID-19
• 13.9 AnimalBiome
  • 13.9.1 AnimalBiome Company Details
  • 13.9.2 AnimalBiome Business Overview and Its Total Revenue
  • 13.9.3 AnimalBiome Gut Microbiome Introduction
  • 13.9.4 AnimalBiome Revenue in Gut Microbiome Business (2015-2020)
  • 13.9.5 AnimalBiome Recent Development and Reaction to COVID-19
• 13.10 Assembly Biosciences
  • 13.10.1 Assembly Biosciences Company Details
  • 13.10.2 Assembly Biosciences Business Overview and Its Total Revenue
  • 13.10.3 Assembly Biosciences Gut Microbiome Introduction
  • 13.10.4 Assembly Biosciences Revenue in Gut Microbiome Business (2015-2020)
  • 13.10.5 Assembly Biosciences Recent Development and Reaction to COVID-19
• 13.11 Enterome BioScience
  • 10.11.1 Enterome BioScience Company Details
  • 10.11.2 Enterome BioScience Business Overview and Its Total Revenue
  • 10.11.3 Enterome BioScience Gut Microbiome Introduction
  • 10.11.4 Enterome BioScience Revenue in Gut Microbiome Business (2015-2020)
  • 10.11.5 Enterome BioScience Recent Development and Reaction to COVID-19

14Analyst's Viewpoints/Conclusions

15Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer